StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) stock

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.01 (-0.76%)

Close on Nov 18, 2026Market cap $3.96MP/E –Yield –

Sonoma Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Sonoma Pharmaceuticals's pe ratio was 2.9× on Jan 31, 2018, against 8.8× a year earlier. Over the last 2 years it ranged from 1.1× to 9.9×, with a median of 3.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2018Jan 31, 20182.9×−0.2
2017Dec 29, 20173.0×−5.8
2015Apr 30, 20158.8×+6.8
2014Dec 31, 20142.0×–

More Sonoma Pharmaceuticals figures

See a number that looks wrong?